Breaking News on Pharmaceutical Technology

Kimtech cleanroom coveralls launched

21-Oct-2009 - Kimberly-Clark Professional has launched Kimtech Pure A5 cleanroom coveralls, for sterile and non-sterile environments, to provide an affordable way to reduce the risk of contamination.

H Lundbeck eschews outsourcing and buys Elaiapharm

20-Oct-2009 - CNS focused drugmaker H Lundbeck says its acquisition of French CMO Elaiapharm represents a cheaper option than third-party manufacturing.

News in brief

FDA approves Cervarix; also Gardasil for men

20-Oct-2009 - The US Food and Drug Administration (FDA) has approved Cervarix for vaccination against HPV and also granted a new indication to its rival Gardasil, which is now permitted for use in men.

People on the move: pharma jobs

20-Oct-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Peregrine Pharmaceuticals, Seaside Therapeutics and Eucodis.

Write for In-PharmaTechnologist.com

19-Oct-2009 - Do you enjoy reading our latest headlines? Then, why not help to write them yourself by working as a freelance correspondent for In-PharmaTechnologist.com?

ACRO wants trials for most biosimilars

15-Oct-2009 - ACRO says while a 12-year exclusivity period for innovative drugs is important for R&D, US legislation should include rules on trials for biosimilars

News in brief

Lilly sells Tippecanoe API site to Evonik

15-Oct-2009 - US drugmaker Eli Lilly will sell its Tippecanoe laboratories API manufacturing unit to Germany’s Evonik Industries.

Dispatches from CPhI

Gene therapy to drive viral and biologics market, says SAFC

14-Oct-2009 - SAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale.

Novartis options Heptares’ Star GPCR tech in $200m deal

13-Oct-2009 - Novartis has optioned rights to apply Heptares Therapeutics’ Star GPCR technology to one of its drug development programmes in a deal that, the UK firm says, could be worth over $200m.

People on the move: pharma jobs

13-Oct-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including elections to ISPE's board and a Roche exec joining Dendreon's board.

CPhI 2009 show preview

08-Oct-2009 - We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.

Court sides with GSK over parallel trade restrictions

08-Oct-2009 - GlaxoSmithKline (GSK) and other pharmas concerned by parallel trade have been given encouragement by Europe’s highest court which said the EC must reconsider the company’s Spanish sale conditions.

MannKind’s shares tumble; deal unlikely in 2009

07-Oct-2009 - MannKind’s share price tumbled by 31 per cent yesterday, just days after it published encouraging safety data for Afresa, because it revealed a partnership deal is unlikely to occur in 2009.

News in brief

Sanofi, Teva and Ratiopharm raided in EC competition probe

07-Oct-2009 - French drug major Sanofi Aventis, Israel's Teva Pharmaceutical Industries and Germany’s Ratiopharm were raided by European Commission (EC) competition officials yesterday as part of an ongoing investigation.

French govt unlikey to relinquish grip on health spending, says BMI

06-Oct-2009 - Despite the government’s “aggressive” promotion of generic drugs, pharmaceutical spending in France will continue to grow, according to new analysis by Business Monitor International (BMI).

GSK’s H1N1 orders total 440m doses

06-Oct-2009 - GSK has won 22 government orders for its H1N1 swine flu vaccine in the past two months, taking total sales to 440m doses which media reports suggest will earn the company £2.2bn ($3.5bn).

Reliance on external partners threatens innovation; experts

06-Oct-2009 - Pharma’s reliance on outsourcing and products developed by biotechs could cause the pace of innovation to “decline considerably”, according to experts that are concerned about the lack of funding for small businesses.

People on the move: pharma jobs

05-Oct-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma space, including appointments at Sigma-Aldrich, Novavax and Pfizer’s CEO taking on an additional role.

Sun says Taro suit is “baseless litigation”

01-Oct-2009 - Sun Pharmaceuticals says the new lawsuit filed against it by Taro Pharmaceuticals is “another unfortunate attempt by the Taro directors to divert Taro's limited resources to assisting the Levitt family in their ongoing refusal to comply with their written agreements.”

FDA proposes cGMP rule for combination products

29-Sep-2009 - The FDA is to establish current good manufacturing practice (cGMP) requirements for combination products to eliminate inconsistencies that could affect product safety and public health.

News in brief

J&J buys 18% of Crucell

29-Sep-2009 - US health care major J&J has paid €302m for an 18 per cent stake in Dutch biotechnology Crucell and announced plans for a collaborative drug development programme.

Unlikely CEE CROs & CMOs can maintain sustainable growth; report

29-Sep-2009 - Fierce competition from India and China means it is unlikely that CROs and CMOs in CEE can generate sustainable growth, according to a report that believes the service model must be a “stepping stone” to creating innovative R&D businesses.

Nycomed plans €75m Russian plant; may up €4.5bn bid for Solvay

28-Sep-2009 - Late last week Swiss drugmaker Solvay confirmed its plan to invest up to $75m (€51m) to build a new manufacturing plant in Yaroslavl, Russia.

Breaking news

Abbott beats Nycomed and UCB in battle for Solvay’s drug unit

28-Sep-2009 - Abbott Laboratories will buy Solvay’s pharmaceutical unit for €4.8bn ($7bn) according to reports released earlier today.